Abstract:Abstract Background: Women comprise more than half of people living with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) worldwide and incomplete immune recovery and metabolic abnormalities affect them deeply. Studies of HIV antiretroviral therapy (ART) have a low female representation in China, we aimed to investigate immune reconstitution and metabolic changes of female HIV-positive cohort in China longitudinally. Methods: HIV-positive women who initiated ART from January 2005 to June 2021 and were followed up regularly at least once a year were included in this study. Immunological indicators (cluster of differentiation 4 [CD4] counts and CD8 counts), viral load (VL), and metabolic indicators were collected at follow-up. All data were collected from the China Disease Prevention and Control Information System (CDPCIS). VL was tested half a year, 1 year after receiving ART, and every other year subsequently according to local policy. CD4/CD8 ratio normalization was considered as the primary outcome and defined as a value ≥1. Incidence rate and probability of CD4/CD8 ratio normalization were estimated through per 100 person-years follow-up (PYFU) and Kaplan–Meier curve, respectively. Multivariate Cox regression was used to identify independent risk factors associated with CD4/CD8 ratio normalization. We further studied the rate of dyslipidemia, hyperuricemia, diabetes, liver injury, and renal injury after ART initiation with the chi-squared tests or Fisher's exact probability tests, and a generalized estimating equation model was used to analyze factors of dyslipidemia and hyperuricemia. Results: A total of 494 female patients with HIV/AIDS started ART within 16 years from January 2005 to June 2021, out of which 301 women were enrolled with a median duration of ART for 4.1 years (interquartile range, 2.3–7.0 years). The overall incidence rate of CD4/CD8 ratio normalization was 8.9 (95% confidence interval [CI], 7.4–10.6) per 100 PYFU, and probabilities of CD4/CD8 normalization after initiating ART at 1 year, 2 years, 5 years, and 10 years follow-up were 11.7%, 23.2%, 44.0%, and 59.0%, respectively. Independent risk factors associated with CD4/CD8 normalization were baseline CD4 cell counts 1000 cells/μL, and more than 6 months from the start of combined ART (cART) to first virological suppression. Longitudinally, the rate of hypercholesterolemia (total cholesterol [TC]) and high triglyceride (TG) showed an increasing trend, while the rate of low high-density lipoprotein cholesterol (HDL) showed a decreasing trend. The rate of hyperuricemia presented a downtrend at follow-up. Although liver and renal injury and diabetes persisted during ART, the rate was not statistically significant. Older age and protease inhibitors were independent risk factors for increase of TC and TG, and ART duration was an independent factor for elevation of TC and recovery of HDL-C. Conclusions: This study showed that women were more likely to normalize CD4/CD8 ratio in comparison with findings reported in the literature even though immune reconstruction was incomplete.

Risk factors and longitudinal changes of dyslipidemia among Chinese people living with HIV receiving antiretroviral therapy

The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou

Progressin the Study of Antiretroviral Therapy Related Cardiovascular Diseases in AIDS Patients

Longitudinal analysis of new-onset non-AIDS-defining diseases among people living with HIV: A real-world observational study

Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study

Hiv Drug Resistance And Its Impact On Antiretroviral Therapy In Chinese Hiv-Infected Patients

Prevalence of echocardiographic abnormalities in HIV-infected adults on long-term combination antiretroviral therapy

Incidence And Associated Factors Of Hiv Drug Resistance In Chinese Hiv-Infected Patients Receiving Antiretroviral Treatment

Successful Virologic Outcomes over Time among HAART-treated HIV-infected Patients.

Increasing Trends of Overweight and Obesity in Treatment-Naive People Living with HIV in Shenzhen from 2014 to 2020: an Emerging Health Concern

Neuropsychiatric Adverse Events Following Antiretroviral Therapy in People Living with HIV: A Real-World Study of Dynamic Trends and Risk Factors in Hangzhou, China.

[Characteristics and Associated Factors of Blood Lipid Trajectories among HIV-infected Patients Receiving Antiretroviral Therapy].

Prevalence of Dyslipidemia among Antiretroviral-Naive HIV-Infected Individuals in China.

Changes in Lipid Indices in HIV+ Cases on HAART.

Correlation of Oral Microbiota with Different Immune Responses to Antiretroviral Therapy in People Living with HIV

Risk Factors and Clinical Prediction Models for Low-Level Viremia in People Living with HIV Receiving Antiretroviral Therapy: an 11-Year Retrospective Study

Changes in atherosclerotic cardiovascular disease risk over time among people living with HIV

Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis

Antiretroviral Regimen Change among People Infected with HIV: Evidence from a Cross-Sectional Study in China

The dynamic risk factors of cardiovascular disease among people living with HIV: a real-world data study

Longitudinal trajectory of the association between quality of life and depression among people living with HIV in China: a mixed effects model